Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Migraine Treatment Market from 2024 to 2025?

The market size for migraine treatment has witnessed robust growth in the past few years. Its worth is predicted to rise from $3.18 billion in 2024 to $3.48 billion in 2025, progressing at a compound annual growth rate (CAGR) of 9.4%. The significant growth observed in the historical period is due to factors such as the rising incidence of migraines, heightened healthcare spending, enhancements in existing drug formulations, spreading clinical research, and the advent of innovative therapies.

What Is the Projected Market Size of the Migraine Treatment Market?

The market for migraine treatments is predicted to experience a rapid expansion in the coming years. The market size is forecasted to surge to $5.32 billion in 2029, with an impressive compound annual growth rate (CAGR) of 11.2%. This predicted growth during the forecast period can be credited to a greater level of awareness and education, the rise of monoclonal antibodies, an increased emphasis on pediatric migraines, the development of non-pharmacological treatments, and worldwide efforts towards migraine research. Looking ahead, significant trends are expected to include progress in therapeutic strategies, the advent of wearable devices and digital therapeutics, the adoption of telemedicine and remote consultations, patient-focused care models, the expansion of the generic drug market, and the introduction of oral CGRP inhibitors.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8126&type=smp

Who are the Major Competitors in the Migraine Treatment Market Outlook?

Major companies operating in the migraine treatment market are Pfizer Inc., Eli Lilly and Company, Amgen Inc., GlaxoSmithKline PLC, Novartis AG, Bayer AG, Allergan PLC, Abbott Laboratories, Allodynic Therapeutics LLC, AOBiome LLC, AstraZeneca PLC, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Limited, Impel Pharmaceuticals Inc., AbbVie Inc., Alder BioPharmaceuticals Inc., Astellas Pharma Inc., Biohaven Pharmaceutical Holding Company Ltd., Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Endo International PLC, Impax Laboratories Inc., Johnson & Johnson Inc., Lannett Company Inc., Lupin Limited, Merck & Co. Inc., Mylan N.V.

What Is Fueling Growth in the Migraine Treatment Market?

The sustained interface with electronic screens is anticipated to drive the growth of the migraine treatment market. This term captures the duration individuals spend in front of electronic displays, including smartphones, tablets, computers, and televisions. The contributing factors to this extended interface include the rise in remote work, e-learning, digital entertainment, and increased dependence on technology for social engagement. Migraine relief concerns the treatment of symptoms that are triggered or exacerbated by extended screen time, which includes medications, lifestyle changes, and the application of ergonomic methods to reduce tension and prevent attacks. For example, the House of Commons Committee, a health agency in the UK Parliament, reported in May 2024 that children’s screen time amplified by 52% in 2022, with nearly 25% of children and young individuals displaying smartphone usage behaviors in line with behavioral addiction. Consequently, this amplified engagement with electronic screens is fuelling the growth of the migraine treatment market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8126&type=smp

Which Migraine Treatment Market Segments Are Growing the Fastest?

The migraine treatment market covered in this report is segmented –

1) By Types: Episodic, Migraine With Aura, Chronic, Other Types

2) By Treatment: Acute Or Abortive Treatment, Preventive Or prophylactic Treatment, Non-Pharmacological Therapies And Devices

3) By End-User: Hospitals, Clinics, Homecare, Other End-users

Subsegments:

1) By Episodic: Frequent Episodic Migraine, Infrequent Episodic Migraine

2) By Migraine With Aura: Visual Aura, Sensory Aura, Speech Or Language Aura

3) By Chronic: Chronic Migraine Without Aura, Chronic Migraine With Aura

4) By Other Types: Hemiplegic Migraine, Retinal Migraine, Menstrual Migraine, Other Specific Types

Which Industry Trends Are Shaping the Future of the Migraine Treatment Market?

The leading trend in the migraine treatment market is the emphasis on product innovations. Renowned organizations in the industry are creating novel solutions such as liquid formulations to maintain their competitive edge. For instance, BioDelivery Sciences International (BDSI), a pharmaceutical company based in the US, debuted Elyxyb (celecoxib oral solution) in January 2022. This solution is designed for on-the-spot treatment of migraines in adults, regardless if they experience aura or not. The oral solution’s form allows for quick absorption in the small intestine, providing faster relief compared to traditional tablets. It’s a particularly significant breakthrough for those suffering from migraines accompanied by nausea and vomiting as it no longer necessitates waiting for a pill to dissolve. Elyxyb stands as the first and only FDA-endorsed ready-to-use oral solution for migraines, offering a more effective and comfortable method of coping with sudden severe migraine pain.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Which Countries Are Leading the Migraine Treatment Market?

North America was the largest region in the migraine treatment market in 2024. The regions covered in the migraine treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8126

This Report Delivers Insight On:

1. How big is the migraine treatment market, and how is it changing globally?

2. Who are the major companies in the migraine treatment market, and how are they performing?

3. What are the key opportunities and risks in the migraine treatment market right now?

4. Which products or customer segments are growing the most in the migraine treatment market?

5. What factors are helping or slowing down the growth of the migraine treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model